Skip to main content
Erschienen in: Journal of Neurology 3/2019

28.06.2018 | Review

Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration

verfasst von: Sonia Podvin, Holly T. Reardon, Katrina Yin, Charles Mosier, Vivian Hook

Erschienen in: Journal of Neurology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Huntington’s disease (HD) is a fatal neurodegenerative disease caused by mutant HTT gene expansions of CAG triplet repeat numbers that are inherited in an autosomal dominant manner. HD patients display multiple clinical features that are correlated with HTT CAG repeat numbers that include age of disease onset, motor dysfunction, cognitive deficits, compromised daily living capacity, and brain neurodegeneration. It is important to understand the significant relationships of the multiple HD clinical deficits correlated with the number of mutant HTT CAG expansions that are the genetic basis for HD disabilities. Therefore, this review highlights the significant correlations of the HD clinical features of age of onset, motor and cognitive disabilities, decline in living capabilities, weight loss, risk of death, and brain neurodegeneration with respect to their associations with CAG repeat lengths of the HTT gene. Quantitative HTT gene expression patterns analyzed in normal adult human brain regions demonstrated its distribution in areas known to undergo neurodegeneration in HD, as well as in other brain regions. Future investigation of the relationships of the spectrum of clinical HD features with mutant HTT molecular mechanisms will be important to gain understanding of how mutant CAG expansions of the HTT gene result in the devastating disabilities of HD patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
6.
Zurück zum Zitat The Huntington’s Disease Collaborative Research Group (1999) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983 The Huntington’s Disease Collaborative Research Group (1999) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
7.
Zurück zum Zitat Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha J-H, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, Bonilla E, Stillings T, Negrette A, Snodgrass SR, Martinez-Jaurrieta MD, Ramos-Arroyo MA, Bickham J, Ramos JS, Marshall F, Shoulson I, Rey GJ, Feigin A, Arnheim N, Acevedo-Cruz A, Acosta L, Alvir J, Fischbeck K, Thompson LM, Young A, Dure L, O’Brien CJ, Paulsen J, Brickman A, Krch D, Peery S, Hogarth P, Higgins DS, Landwehrmeyer B, U.S.-Venezuela Collaborative Research Project (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498–3503. https://doi.org/10.1073/pnas.0308679101 CrossRefPubMedPubMedCentral Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha J-H, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, Bonilla E, Stillings T, Negrette A, Snodgrass SR, Martinez-Jaurrieta MD, Ramos-Arroyo MA, Bickham J, Ramos JS, Marshall F, Shoulson I, Rey GJ, Feigin A, Arnheim N, Acevedo-Cruz A, Acosta L, Alvir J, Fischbeck K, Thompson LM, Young A, Dure L, O’Brien CJ, Paulsen J, Brickman A, Krch D, Peery S, Hogarth P, Higgins DS, Landwehrmeyer B, U.S.-Venezuela Collaborative Research Project (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498–3503. https://​doi.​org/​10.​1073/​pnas.​0308679101 CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, Bylsma FW, Pearlson GD, Ross CA (1997) Longitudinal change in basal ganglia volume in patients with Huntington’s disease. Neurology 48:394–399CrossRefPubMed Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, Bylsma FW, Pearlson GD, Ross CA (1997) Longitudinal change in basal ganglia volume in patients with Huntington’s disease. Neurology 48:394–399CrossRefPubMed
10.
Zurück zum Zitat Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA (1996) Trinucleotide repeat length and clinical progression in Huntington’s disease. Neurology 46:527–531CrossRefPubMed Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA (1996) Trinucleotide repeat length and clinical progression in Huntington’s disease. Neurology 46:527–531CrossRefPubMed
12.
Zurück zum Zitat Kieburtz K, MacDonald M, Shih C, Feigin A, Steinberg K, Bordwell K, Zimmerman C, Srinidhi J, Sotack J, Gusella J (1994) Trinucleotide repeat length and progression of illness in Huntington’s disease. J Med Genet 31:872–874CrossRefPubMedPubMedCentral Kieburtz K, MacDonald M, Shih C, Feigin A, Steinberg K, Bordwell K, Zimmerman C, Srinidhi J, Sotack J, Gusella J (1994) Trinucleotide repeat length and progression of illness in Huntington’s disease. J Med Genet 31:872–874CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Lee J-M, Ramos EM, Lee J-H, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJA, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB, REGISTRY study of the European Huntington’s Disease Network, Myers RH, HD-MAPS Study Group, MacDonald ME, Gusella JF, COHORT study of the HSG (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690–695. https://doi.org/10.1212/WNL.0b013e318249f683 CrossRefPubMedPubMedCentral Lee J-M, Ramos EM, Lee J-H, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJA, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB, REGISTRY study of the European Huntington’s Disease Network, Myers RH, HD-MAPS Study Group, MacDonald ME, Gusella JF, COHORT study of the HSG (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690–695. https://​doi.​org/​10.​1212/​WNL.​0b013e318249f683​ CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Rinaldi C, Salvatore E, Giordano I, De Matteis S, Tucci T, Cinzia VR, Rossi F, Castaldo I, Morra VB, Di Maio L, Filla A, De Michele G (2012) Predictors of survival in a Huntington’s disease population from southern Italy. Can J Neurol Sci J Can Sci Neurol 39:48–51CrossRef Rinaldi C, Salvatore E, Giordano I, De Matteis S, Tucci T, Cinzia VR, Rossi F, Castaldo I, Morra VB, Di Maio L, Filla A, De Michele G (2012) Predictors of survival in a Huntington’s disease population from southern Italy. Can J Neurol Sci J Can Sci Neurol 39:48–51CrossRef
16.
Zurück zum Zitat Trembath MK, Horton ZA, Tippett L, Hogg V, Collins VR, Churchyard A, Velakoulis D, Roxburgh R, Delatycki MB (2010) A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov Disord Off J Mov Disord Soc 25:1444–1450. https://doi.org/10.1002/mds.23108 CrossRef Trembath MK, Horton ZA, Tippett L, Hogg V, Collins VR, Churchyard A, Velakoulis D, Roxburgh R, Delatycki MB (2010) A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov Disord Off J Mov Disord Soc 25:1444–1450. https://​doi.​org/​10.​1002/​mds.​23108 CrossRef
18.
Zurück zum Zitat Andresen JM, Gayán J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, US Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44–50. https://doi.org/10.1136/jmg.2006.045153 CrossRefPubMed Andresen JM, Gayán J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, US Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44–50. https://​doi.​org/​10.​1136/​jmg.​2006.​045153 CrossRefPubMed
19.
Zurück zum Zitat Andresen JM, Gayán J, Djoussé L, Roberts S, Brocklebank D, Cherny SS, US-Venezuela Collaborative Research Group, HD MAPS Collaborative Research Group, Cardon LR, Gusella JF, MacDonald ME, Myers RH, Housman DE, Wexler NS (2007) The relationship between CAG repeat length and age of onset differs for Huntington’s disease patients with juvenile onset or adult onset. Ann Hum Genet 71:295–301. https://doi.org/10.1111/j.1469-1809.2006.00335.x CrossRefPubMed Andresen JM, Gayán J, Djoussé L, Roberts S, Brocklebank D, Cherny SS, US-Venezuela Collaborative Research Group, HD MAPS Collaborative Research Group, Cardon LR, Gusella JF, MacDonald ME, Myers RH, Housman DE, Wexler NS (2007) The relationship between CAG repeat length and age of onset differs for Huntington’s disease patients with juvenile onset or adult onset. Ann Hum Genet 71:295–301. https://​doi.​org/​10.​1111/​j.​1469-1809.​2006.​00335.​x CrossRefPubMed
20.
21.
Zurück zum Zitat Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M, Predict-HD Investigators and Coordinators of the Huntington Study Group (2008) Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79:874–880. https://doi.org/10.1136/jnnp.2007.128728 CrossRefPubMed Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M, Predict-HD Investigators and Coordinators of the Huntington Study Group (2008) Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79:874–880. https://​doi.​org/​10.​1136/​jnnp.​2007.​128728 CrossRefPubMed
22.
Zurück zum Zitat Alonso ME, Yescas P, Rasmussen A, Ochoa A, Macías R, Ruiz I, Suástegui R (2002) Homozygosity in Huntington’s disease: new ethical dilemma caused by molecular diagnosis. Clin Genet 61:437–442CrossRefPubMed Alonso ME, Yescas P, Rasmussen A, Ochoa A, Macías R, Ruiz I, Suástegui R (2002) Homozygosity in Huntington’s disease: new ethical dilemma caused by molecular diagnosis. Clin Genet 61:437–442CrossRefPubMed
23.
Zurück zum Zitat Dürr A, Hahn-Barma V, Brice A, Pêcheux C, Dodé C, Feingold J (1999) Homozygosity in Huntington’s disease. J Med Genet 36:172–173PubMedPubMedCentral Dürr A, Hahn-Barma V, Brice A, Pêcheux C, Dodé C, Feingold J (1999) Homozygosity in Huntington’s disease. J Med Genet 36:172–173PubMedPubMedCentral
24.
Zurück zum Zitat Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D, Bachoud-Lévi A-C, Simpson SA, Delatycki M, Maglione V, Hayden MR, Donato SD (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain J Neurol 126:946–955CrossRef Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D, Bachoud-Lévi A-C, Simpson SA, Delatycki M, Maglione V, Hayden MR, Donato SD (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain J Neurol 126:946–955CrossRef
26.
Zurück zum Zitat Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP (2008) The relationship between CAG repeat length and clinical progression in Huntington’s disease. Mov Disord Off J Mov Disord Soc 23:1223–1227. https://doi.org/10.1002/mds.21988 CrossRef Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP (2008) The relationship between CAG repeat length and clinical progression in Huntington’s disease. Mov Disord Off J Mov Disord Soc 23:1223–1227. https://​doi.​org/​10.​1002/​mds.​21988 CrossRef
29.
Zurück zum Zitat Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I (2000) Rate of functional decline in Huntington’s disease. Huntingt Study Group Neurol 54:452–458 Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I (2000) Rate of functional decline in Huntington’s disease. Huntingt Study Group Neurol 54:452–458
30.
Zurück zum Zitat Stout JC, Queller S, Baker KN, Cowlishaw S, Sampaio C, Fitzer-Attas C, Borowsky B, HD-CAB Investigators (2014) HD-CAB: a cognitive assessment battery for clinical trials inHuntington’s disease 1,2,3. Mov Disord Off J Mov Disord Soc 29:1281–1288. https://doi.org/10.1002/mds.25964 CrossRef Stout JC, Queller S, Baker KN, Cowlishaw S, Sampaio C, Fitzer-Attas C, Borowsky B, HD-CAB Investigators (2014) HD-CAB: a cognitive assessment battery for clinical trials inHuntington’s disease 1,2,3. Mov Disord Off J Mov Disord Soc 29:1281–1288. https://​doi.​org/​10.​1002/​mds.​25964 CrossRef
31.
Zurück zum Zitat Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, TRACK-HD Investigators (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637–649. https://doi.org/10.1016/S1474-4422(13)70088-7 CrossRefPubMed Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, TRACK-HD Investigators (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637–649. https://​doi.​org/​10.​1016/​S1474-4422(13)70088-7 CrossRefPubMed
37.
Zurück zum Zitat Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577CrossRefPubMed Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577CrossRefPubMed
38.
Zurück zum Zitat Culjkovic B, Stojkovic O, Vojvodic N, Svetel M, Rakic L, Romac S, Kostic V (1999) Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington’s disease. J Neurol 246:1090–1093CrossRefPubMed Culjkovic B, Stojkovic O, Vojvodic N, Svetel M, Rakic L, Romac S, Kostic V (1999) Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington’s disease. J Neurol 246:1090–1093CrossRefPubMed
40.
Zurück zum Zitat Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, Fischl B, Salat DH, Hersch SM (2011) A tale of two factors: what determines the rate of progression in Huntington’s disease? A longitudinal MRI study. Mov Disord Off J Mov Disord Soc 26:1691–1697. https://doi.org/10.1002/mds.23762 CrossRef Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, Fischl B, Salat DH, Hersch SM (2011) A tale of two factors: what determines the rate of progression in Huntington’s disease? A longitudinal MRI study. Mov Disord Off J Mov Disord Soc 26:1691–1697. https://​doi.​org/​10.​1002/​mds.​23762 CrossRef
42.
Zurück zum Zitat Wu D, Faria AV, Younes L, Mori S, Brown T, Johnson H, Paulsen JS, Ross CA, Miller MI, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2017) Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington’s disease. Hum Brain Mapp 38:5035–5050. https://doi.org/10.1002/hbm.23713 CrossRefPubMedPubMedCentral Wu D, Faria AV, Younes L, Mori S, Brown T, Johnson H, Paulsen JS, Ross CA, Miller MI, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2017) Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington’s disease. Hum Brain Mapp 38:5035–5050. https://​doi.​org/​10.​1002/​hbm.​23713 CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Klöppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, Rothwell JC, Langbehn D, Tabrizi SJ, TRACK-On Investigators (2016) Natural variation in sensory-motor white matter organization influences manifestations of Huntington’s disease. Hum Brain Mapp 37:4615–4628. https://doi.org/10.1002/hbm.23332 CrossRefPubMedPubMedCentral Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Klöppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, Rothwell JC, Langbehn D, Tabrizi SJ, TRACK-On Investigators (2016) Natural variation in sensory-motor white matter organization influences manifestations of Huntington’s disease. Hum Brain Mapp 37:4615–4628. https://​doi.​org/​10.​1002/​hbm.​23332 CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington’s disease: a multimodal imaging study. Hum Brain Mapp 32:258–270. https://doi.org/10.1002/hbm.21008 CrossRefPubMed Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington’s disease: a multimodal imaging study. Hum Brain Mapp 32:258–270. https://​doi.​org/​10.​1002/​hbm.​21008 CrossRefPubMed
49.
Zurück zum Zitat Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL (2014) The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease. JAMA Neurol 71:1520–1528. https://doi.org/10.1001/jamaneurol.2014.1954 CrossRefPubMed Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL (2014) The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease. JAMA Neurol 71:1520–1528. https://​doi.​org/​10.​1001/​jamaneurol.​2014.​1954 CrossRefPubMed
53.
Zurück zum Zitat Weeks RA, Ceballos-Baumann A, Piccini P, Boecker H, Harding AE, Brooks DJ (1997) Cortical control of movement in Huntington’s disease. A PET activation study. Brain J Neurol 120(Pt 9):1569–1578CrossRef Weeks RA, Ceballos-Baumann A, Piccini P, Boecker H, Harding AE, Brooks DJ (1997) Cortical control of movement in Huntington’s disease. A PET activation study. Brain J Neurol 120(Pt 9):1569–1578CrossRef
55.
Zurück zum Zitat Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2013) Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingt Dis 2:477–489. https://doi.org/10.3233/JHD-130076 CrossRef Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2013) Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingt Dis 2:477–489. https://​doi.​org/​10.​3233/​JHD-130076 CrossRef
57.
Zurück zum Zitat Braak H, Braak E (1992) Allocortical involvement in Huntington’s disease. Neuropathol Appl Neurobiol 18:539–547CrossRefPubMed Braak H, Braak E (1992) Allocortical involvement in Huntington’s disease. Neuropathol Appl Neurobiol 18:539–547CrossRefPubMed
63.
Zurück zum Zitat Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, Strand A, Torcassi C, Savage J, Hurlburt A, Cha GH, Ukani L, Chepanoske CL, Zhen Y, Sahasrabudhe S, Olson J, Kurschner C, Ellerby LM, Peltier JM, Botas J, Hughes RE (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 3(5):e82CrossRefPubMedPubMedCentral Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, Strand A, Torcassi C, Savage J, Hurlburt A, Cha GH, Ukani L, Chepanoske CL, Zhen Y, Sahasrabudhe S, Olson J, Kurschner C, Ellerby LM, Peltier JM, Botas J, Hughes RE (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 3(5):e82CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Culver BP, Savas JN, Park SK, Choi JH, Zheng S, Zeitlin SO, Yates JR 3rd, Tanese N (2012) Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. J Biol Chem 28:21599–21614. https://doi.org/10.1074/jbc.M112.359307 CrossRef Culver BP, Savas JN, Park SK, Choi JH, Zheng S, Zeitlin SO, Yates JR 3rd, Tanese N (2012) Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. J Biol Chem 28:21599–21614. https://​doi.​org/​10.​1074/​jbc.​M112.​359307 CrossRef
68.
Zurück zum Zitat Macdonald V, Halliday G (2002) Pyramidal cell loss in motor cortices in Huntington’s disease. Neurobiol Dis 10:378–386CrossRefPubMed Macdonald V, Halliday G (2002) Pyramidal cell loss in motor cortices in Huntington’s disease. Neurobiol Dis 10:378–386CrossRefPubMed
69.
70.
Zurück zum Zitat Harrington DL, Rubinov M, Durgerian S, Mourany L, Reece C, Koenig K, Bullmore E, Long JD, Paulsen JS, PREDICT-HD investigators of the Huntington Study Group, Rao SM (2015) Network topology and functional connectivity disturbances precede the onset of Huntington’s disease. Brain J Neurol 138:2332–2346. https://doi.org/10.1093/brain/awv145 CrossRef Harrington DL, Rubinov M, Durgerian S, Mourany L, Reece C, Koenig K, Bullmore E, Long JD, Paulsen JS, PREDICT-HD investigators of the Huntington Study Group, Rao SM (2015) Network topology and functional connectivity disturbances precede the onset of Huntington’s disease. Brain J Neurol 138:2332–2346. https://​doi.​org/​10.​1093/​brain/​awv145 CrossRef
74.
Zurück zum Zitat Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O’Regan A, Queller S, Frost C, Leavitt BR, Dürr A, Roos R, Owen G, Borowsky B, Tabrizi SJ, Stout JC, TRACK-HD Investigators (2016) Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington’s disease. J Int Neuropsychol Soc JINS 22:595–608. https://doi.org/10.1017/S1355617716000321 CrossRefPubMed Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O’Regan A, Queller S, Frost C, Leavitt BR, Dürr A, Roos R, Owen G, Borowsky B, Tabrizi SJ, Stout JC, TRACK-HD Investigators (2016) Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington’s disease. J Int Neuropsychol Soc JINS 22:595–608. https://​doi.​org/​10.​1017/​S135561771600032​1 CrossRefPubMed
76.
Zurück zum Zitat Majid DSA, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM (2011) Basal ganglia atrophy in prodromal Huntington’s disease is detectable over one year using automated segmentation. Mov Disord Off J Mov Disord Soc 26:2544–2551. https://doi.org/10.1002/mds.23912 CrossRef Majid DSA, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM (2011) Basal ganglia atrophy in prodromal Huntington’s disease is detectable over one year using automated segmentation. Mov Disord Off J Mov Disord Soc 26:2544–2551. https://​doi.​org/​10.​1002/​mds.​23912 CrossRef
78.
Zurück zum Zitat de Azevedo PC, Guimarães RP, Piccinin CC, Piovesana LG, Campos LS, Zuiani JR, Tamashiro EM, Pinheiro G, Amato-Filho AC, Cendes F, Lopes-Cendes I, D’Abreu A (2017) cerebellar gray matter alterations in huntington disease: a voxel-based morphometry study. Cerebellum Lond Engl 16:923–928. https://doi.org/10.1007/s12311-017-0865-6 CrossRef de Azevedo PC, Guimarães RP, Piccinin CC, Piovesana LG, Campos LS, Zuiani JR, Tamashiro EM, Pinheiro G, Amato-Filho AC, Cendes F, Lopes-Cendes I, D’Abreu A (2017) cerebellar gray matter alterations in huntington disease: a voxel-based morphometry study. Cerebellum Lond Engl 16:923–928. https://​doi.​org/​10.​1007/​s12311-017-0865-6 CrossRef
79.
Zurück zum Zitat Rüb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel J-P, Lange H, Korf H-W, den Dunnen W (2014) Huntington’s disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol Zurich Switz 24:247–260. https://doi.org/10.1111/bpa.12115 CrossRef Rüb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel J-P, Lange H, Korf H-W, den Dunnen W (2014) Huntington’s disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol Zurich Switz 24:247–260. https://​doi.​org/​10.​1111/​bpa.​12115 CrossRef
Metadaten
Titel
Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration
verfasst von
Sonia Podvin
Holly T. Reardon
Katrina Yin
Charles Mosier
Vivian Hook
Publikationsdatum
28.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8940-6

Weitere Artikel der Ausgabe 3/2019

Journal of Neurology 3/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.